NDLI: The future of food allergy therapeutics

Please wait, while we are loading the content...

Springer Seminars in Immunopathology : Volume 39

Springer Seminars in Immunopathology : Volume 38

Springer Seminars in Immunopathology : Volume 37

Springer Seminars in Immunopathology : Volume 36

Springer Seminars in Immunopathology : Volume 35

Springer Seminars in Immunopathology : Volume 34

Springer Seminars in Immunopathology : Volume 34, Issue 6, November 2012

Springer Seminars in Immunopathology : Volume 34, Issue 5, September 2012

Introduction to Special Issue on Food Allergy

Innate immunostimulatory properties of allergens and their relevance to food allergy

Mucosal antibodies in the regulation of tolerance and allergy to foods

Food-induced anaphylaxis: mast cells as modulators of anaphylactic severity

Early life precursors, epigenetics, and the development of food allergy

Microbial regulation of allergic responses to food

Immunological mechanisms for desensitization and tolerance in food allergy

The future of food allergy therapeutics

Eosinophilic gastrointestinal diseases—clinically diverse and histopathologically confounding

Springer Seminars in Immunopathology : Volume 34, Issue 4, July 2012

Springer Seminars in Immunopathology : Volume 34, Issue 3, May 2012

Springer Seminars in Immunopathology : Volume 34, Issue 2, March 2012

Springer Seminars in Immunopathology : Volume 34, Issue 1, January 2012

Springer Seminars in Immunopathology : Volume 33

Springer Seminars in Immunopathology : Volume 32

Springer Seminars in Immunopathology : Volume 31

Springer Seminars in Immunopathology : Volume 30

Springer Seminars in Immunopathology : Volume 29

Springer Seminars in Immunopathology : Volume 28

Springer Seminars in Immunopathology : Volume 27

Springer Seminars in Immunopathology : Volume 26

Springer Seminars in Immunopathology : Volume 25

Springer Seminars in Immunopathology : Volume 24

Springer Seminars in Immunopathology : Volume 23

Springer Seminars in Immunopathology : Volume 22

Springer Seminars in Immunopathology : Volume 21

Springer Seminars in Immunopathology : Volume 20

Springer Seminars in Immunopathology : Volume 19

Springer Seminars in Immunopathology : Volume 18

The future of food allergy therapeutics

Content Provider	Springer Nature Link
Author	Henson, Michele Burks, A. Wesley
Copyright Year	2012
Abstract	Food allergy is increasing in prevalence in westernized countries, leading to significant morbidity including nutritional deficiencies and growth delay as well as psychosocial burdens and the potential for fatal anaphylaxis. There is currently no effective form of therapy, and the mainstay of treatment remains strict avoidance. However, there are a number of promising therapeutic strategies currently being investigated for the treatment of food allergies. Allergen-specific approaches, such as various forms of immunotherapy, have been a major focus of investigation and appear to be promising methods of desensitization. More recently, the addition of anti-IgE monoclonal antibodies (mAbs) to immunotherapy regimens has been studied. Early work with antigen-fixed leukocytes in a murine model has shown promise in inducing tolerance, as have vaccines containing modified recombinant food proteins coadministered with heat-killed Escherichia coli. Nonspecific approaches include a Chinese herbal formulation, anti-IgE mAbs, and Trichuris suis ova therapy. The array of treatment modalities currently being investigated increases the likelihood of finding one or more effective therapies for the treatment of food allergy.
Starting Page	703
Ending Page	714
Page Count	12
File Format	PDF
ISSN	18632297
Journal	Springer Seminars in Immunopathology
Volume Number	34
Issue Number	5
e-ISSN	18632300
Language	English
Publisher	Springer-Verlag
Publisher Date	2012-06-27
Publisher Place	Berlin, Heidelberg
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	Food allergy Oral immunotherapy (OIT) Double-blind Placebo-controlled food challenge (DBPCFC) Anti-IgE antibody/omalizumab Desensitization Immunology Internal Medicine
Content Type	Text
Resource Type	Article
Subject	Immunology and Allergy Immunology

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

The Use of Omalizumab in Food Oral Immunotherapy

Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapy

A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy.

Immunotherapy and Oral Immunotherapy with Omalizumab for Food Allergies

Current and future applications of the anti-IgE antibody omalizumab

Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab

Molecular and immunological characterisation of peanut ingredients for double blind placebo controlled food challenge (DBPCFC)

Is molecular allergology cost-effective and cost saving in children with suspected peanut allergy compared to double blind placebo controlled food challenge (DBPCFC), open oral food challenge and skin prick test in Sweden?

Immunological mechanisms for desensitization and tolerance in food allergy

The future of food allergy therapeutics

Similar Documents

The Use of Omalizumab in Food Oral Immunotherapy

Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapy

A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy.

Immunotherapy and Oral Immunotherapy with Omalizumab for Food Allergies

Current and future applications of the anti-IgE antibody omalizumab

Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab

Molecular and immunological characterisation of peanut ingredients for double blind placebo controlled food challenge (DBPCFC)

Is molecular allergology cost-effective and cost saving in children with suspected peanut allergy compared to double blind placebo controlled food challenge (DBPCFC), open oral food challenge and skin prick test in Sweden?

Immunological mechanisms for desensitization and tolerance in food allergy

The future of food allergy therapeutics